Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer - Poll - MDSpire

Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer

  • By

  • Su Zhang

  • Hanghao Zhang

  • Xingwang Dong

  • Zhen Qi

  • Yingjun Ma

  • Hong Chang

  • Ye Li

  • Wei Zhang

  • June 8, 2026

  • 0 min

Share

Original Source(s)

Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer

  • by Su Zhang, Hanghao Zhang, Xingwang Dong, Zhen Qi, Yingjun Ma, Hong Chang, Ye Li, Wei Zhang

  • June 8, 2026

Related Content

Lobectomy versus sublobar resection for stage I non-small cell lung cancer: an umbrella review of evidence quality, overlap, surgical-extent heterogeneity, and survival outcomes

Evaluating the efficacy and safety of first-line immunotherapy for metastatic triple-negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials with a focus on PD-L1 expression

First-line serplulimab plus chemotherapy versus chemotherapy alone in small-cell lung cancer patients with brain metastases: a multicenter, prospective cohort study